EPCAM and neoplasm: To address this further, we used flow cytometry to investigate the expression of these checkpoint molecules in tumor epithelium (EpCAM)_compared with mesenchymal cell susbets and vasculature (CD31) in a smaller cohort of patients (n = 12) (Fig. 3a).